JWCA has advised CORE SCIENTIFIC on capital market transactions with nearly $1.1 billion in transaction value
December 2024: JWCA advises Core Scientific on its upsized zero coupon $625 million convertible issuance
August 2024: JWCA advises Core Scientific on its upsized $460 million convertible issuance